Agilent Technologies, Inc. · NYSE:A
Agilent Technologies — Merger or Acquisition (July 2019)
4 slides from Agilent Technologies's merger presentation, Jul 11, 2019
Slide 1: Agilent to Acquire BioTek Instruments Inc.
Agilent to Acquire BioTek Instruments Inc. July 11, 2019
Slide 2: Safe Harbor
Safe Harbor This presentation contains forward-looking statements (including, without limitation, information and future guidance on the company’s goals, priorities, revenue, revenue growth, earnings per share, operating margin, operating cash flow, capital expenditures, capital allocation, growth o
Slide 3: Strategic Rationale for the deal
Strategic Rationale for the deal • A leading producer of instrumentation and • Complementary to Agilent’s capabilities and assays used for analyzing live cells - Imaging position in cell analysis; the combined and Microscopy Systems, Microplate Readers companies will lead live-cell analysis - an are
Slide 4: Transaction highlights
Transaction highlights Purchase Price: $1,165M ($1,050M - net of anticipated tax benefits), representing approx. 22x FY19 EBIDTA (1) $162M 12% FY18 Revenue CAGR(4) over last three years ROIC(2): Expect to achieve HSD in 5 years Asia, Margins: In line with Agilent margins Govt, 10% Other, 4% 10% Chin
Agilent Technologies — Merger or Acquisition (July 2019) on 6ix